Research & Development

Ivan Kairatov stands at the forefront of biopharmaceutical innovation, bringing years of dedicated research in oncology to the challenge of treating refractory cancers. His recent collaborative work with international teams from the Netherlands, Italy, and Slovakia has shed new light on germ cell

We are joined by Ivan Kairatov, a biopharma expert with deep insights into the intricate world of drug research and development. In our conversation, we’ll explore the high-stakes landscape of regulatory approvals, touching on Bristol Myers Squibb's pivotal new cancer therapy, the challenging path

While traditional breast cancer screening saves lives, its methods often involve discomfort, radiation, and high costs, creating significant barriers for many. A new wave of technology is emerging to change that. Ultra-Low Field (ULF) MRI is gaining traction as a potential solution, promising a

The long shadow cast by Alzheimer's disease over millions of families has historically been darkened by the inability to see its approach, but a new class of predictive blood biomarker technology is beginning to part the clouds. The development of predictive models using a single blood sample

The rapid ascent of GLP-1 agonists as a cornerstone therapy for diabetes and obesity has been nothing short of revolutionary, yet this widespread adoption brings into sharp focus the critical need to look beyond their celebrated benefits and scrutinize their full safety profile. As millions of

For more than four decades, humanity has been locked in a high-stakes biological chess match with HIV, a virus so well-studied that its every move seemed mapped and countered. Yet, a recent discovery has revealed a stunning blind spot in our understanding, a hidden structural vulnerability that